MOUNT LAUREL, N.J., April 3, 2008 /PRNewswire-FirstCall/ -- MedQuist Inc. (Pink Sheets: MEDQ.PK) announces that Anna Jaques Hospital, a 123-bed acute care community hospital in Newburyport, Mass., has selected MedQuist Technology Solutions to deliver a complete clinical documentation solution including dictation, transcription and speech recognition. Anna Jaques produces more than 80,000 radiology reports annually and is home to a nationally recognized Wound Healing Center.
MedQuist's transcription and speech recognition solutions will be used in the radiology department, wound center and other areas of Anna Jaques to reduce report backlog, manage and improve workflow, and provide more timely and efficient service to the physicians. Explains James Borek, director of Diagnostic Imaging, "We were having trouble finding people in our area to do the transcription. With our PACS and filmless radiology, we try to do everything quickly here and keep turnaround time to a minimum, but due to fluctuations in our medical transcriptionists' (MTs) availability, the physicians were not getting reports in as timely a manner as they wanted. They need instant access to the radiologists' diagnoses."
According to Robert Buchanan, chief information officer, "Our report volume has increased, and as we have added services that require transcription, we couldn't keep up, even with outside assistance. We selected the MedQuist Enterprise Platform because it would not result in any disruption to our current physician dictation process, and because it was cost-effective for a small community hospital such as ours. We do not believe it will be a complex solution to implement; it will be a simple transition as we train our MTs to become editors and try to eliminate outsourcing."
Part of Buchanan's confidence comes from the facility's previous relationship with MedQuist service personnel. "That was a big factor in our purchasing decision," he says. "We need to augment our limited resources by utilizing the excellent support provided by MedQuist field engineers. Maintaining uptime is key for us." With the MedQuist Enterprise Platform, Anna Jaques will also be taking advantage of the stability and security of an Application Service Provider (ASP) solution.
Scott Bennett, MedQuist senior vice president of Sales and Marketing, comments, "We are glad to enter into this partnership with Anna Jaques and provide them with the same leading-edge technology solutions deployed in large, urban facilities."
Adds Borek, "With the introduction of the MedQuist technology suite, we hope to become the first choice for diagnostic referrals in the region."
About Anna Jaques
Anna Jaques Hospital is a 123-bed acute care community hospital serving 17 cities and towns in the Merrimack Valley. Services include the number one wound healing center in the nation, recognized by National Healing Corporation (NHC) for its 96.6 percent healing rate; an endocrinology and diabetes center; Primary Stroke Center; Level III Trauma Center; joint replacement program; and a birth center with neonatal care. Anna Jaques was the first hospital on the North Shore to offer fully digital operating room suites, high definition endoscopy equipment and groundbreaking total imaging MRI technology.
MedQuist is the largest Medical Transcription Service Organization (MTSO) in the world, and a leader in technology-enabled clinical documentation workflow. MedQuist's enterprise solutions -- including mobile voice capture devices, speech recognition, Web-based workflow platforms, and global network of medical editors -- help healthcare facilities improve patient care, increase physician satisfaction, and lower operational costs. For more information, please visit http://www.medquist.com.
"Safe Harbor" Statement under the U.S. Private Securities Litigation Reform Act of 1995: Statements in this press release regarding MedQuist's business which are not historical facts are "forward-looking statements" that involve risks and uncertainties. Actual outcomes and results may differ materially from what is expressed or forecasted in forward-looking statements. As a result, forward-looking statements speak only as of the date they were made, and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
|SOURCE MedQuist Inc.|
Copyright©2008 PR Newswire.
All rights reserved